Citadel Advisors
CODX

Citadel Advisors’s Co-Diagnostics CODX Stock Holding History

Citadel Advisors’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-353
Closed -$3.84K – 12814
2025
Q3 		$3.64K Buy
+353
New +$3.28K ﹤0.01% 12582
2025
Q2 		– Sell
-6,304
Closed -$59K – 12845
2025
Q1 		$58.6K Buy
6,304
+5,755
+1,048% +$110K ﹤0.01% 12140
2024
Q4 		$12.3K Sell
549
-298
-35% -$9.41K ﹤0.01% 13503
2024
Q3 		$31.8K Sell
847
-946
-53% -$36.3K ﹤0.01% 12377
2024
Q2 		$67.2K Sell
1,793
-638
-26% -$23.2K ﹤0.01% 11423
2024
Q1 		$81.7K Sell
2,431
-791
-25% -$28.7K ﹤0.01% 11629
2023
Q4 		$129K Buy
3,222
+813
+34% +$28.7K ﹤0.01% 10612
2023
Q3 		$76.6K Buy
2,409
+560
+30% +$21.2K ﹤0.01% 11224
2023
Q2 		$61.6K Buy
1,849
+743
+67% +$28.4K ﹤0.01% 11557
2023
Q1 		$49.1K Buy
1,106
+345
+45% +$27.7K ﹤0.01% 12171
2022
Q4 		$57.5K Buy
+761
New +$71.3K ﹤0.01% 11952
2022
Q3 		– Sell
-4,089
Closed -$572K – 12729
2022
Q2 		$688K Buy
4,089
+1,319
+48% +$201K ﹤0.01% 7909
2022
Q1 		$514K Buy
2,770
+275
+11% +$56.9K ﹤0.01% 9321
2021
Q4 		$669K Sell
2,495
-1,530
-38% -$401K ﹤0.01% 8943
2021
Q3 		$1.18M Sell
4,025
-3,481
-46% -$1.02M ﹤0.01% 7732
2021
Q2 		$1.86M Buy
7,506
+3,644
+94% +$937K ﹤0.01% 6789
2021
Q1 		$1.1M Buy
3,862
+2,832
+275% +$1.13M ﹤0.01% 7863
2020
Q4 		$287K Sell
1,030
-625
-38% -$232K ﹤0.01% 9150
2020
Q3 		$675K Sell
1,655
-7,653
-82% -$3.93M ﹤0.01% 6755
2020
Q2 		$5.4M Buy
9,308
+5,926
+175% +$2.7M ﹤0.01% 2985
2020
Q1 		$773K Buy
+3,382
New +$586K ﹤0.01% 5757
2019
Q4 		– Sell
-680
Closed -$21K – 9174
2019
Q3 		$21K Buy
+680
New +$22.6K ﹤0.01% 8924
2019
Q1 		– Sell
-776
Closed -$34K – 9320
2018
Q4 		$34K Buy
776
+318
+69% +$20.8K ﹤0.01% 8582
2018
Q3 		$36K Buy
+458
New +$45.2K ﹤0.01% 8878
2018
Q2 		– Sell
-499
Closed -$33K – 8862
2018
Q1 		$33K Buy
+499
New +$38.1K ﹤0.01% 8028

Other funds holding CODX

PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $2.77B AUM 22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Citadel Advisors's CODX Position: Q4 2025 in Review

Citadel Advisors sold out of Co-Diagnostics (CODX) in Q4 2025, closing a stake of 353 shares — an estimated $3.84K sold.

Citadel Advisors first reported a position in CODX in Q1 2018 and held it in 25 quarters. The position peaked at $5.4M in Q2 2020. 30 funds tracked by Wall St. Rank hold CODX as of Q4 2025.

  • Citadel Advisors reported no remaining Co-Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 353 Co-Diagnostics shares in Q4 2025, an estimated $3.84K.
  • Citadel Advisors first reported a position in Co-Diagnostics in Q1 2018 and held it in 25 quarters.
  • Citadel Advisors's Co-Diagnostics position peaked at $5.4M in Q2 2020.
  • 30 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.